NPPA notified regarding the fixation of the Atorvastatin calcium IP eq. to Atorvastatin 10 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd.

Feb 20, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 19, 2025, notified regarding the fixation of the retail price of Atorvastatin calcium IP eq. to Atorvastatin 10 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg for M/s Pure and Cure Healthcare Pvt. Ltd.

It has fixed the rate at Rs. 14.02/- for each uncoated bilayered tablet containing: Atorvastatin calcium IP eq. to Atorvastatin 10 mg + Clopidogrel bisulphate IP e.q. to Clopidogrel 75 mg.

[Notification no. - 19(4444)/2025/DP/NPPA/Div.II]

View Document 1

Bookmark

Related Updates

View More Related Updates


Alternate Text

Get updates on the go on RegUpdate Mobile App.

Alternate Text
✦ NEW  ·  AI ASSISTANT